Page last updated: 2024-08-23

alovudine and Invasiveness, Neoplasm

alovudine has been researched along with Invasiveness, Neoplasm in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buck, AK; Eckel, F; Herrmann, K; Hillerer, C; Krause, BJ; Langer, R; Schmid, RM; Schmidt, S; Schuster, T; Schwaiger, M; Wester, HJ; Wieder, HA1
Kjaer, A; Madsen, J; Persson, M; Ploug, M; Rasmussen, P1
Kuo, WH; Liu, CJ; Wang, J; Yen, RF1
Been, LB; Cobben, DC; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ1
Buck, AK; Glatting, G; Halter, G; Hetzel, M; Kratochwil, C; Mattfeldt, T; Möller, P; Mottaghy, FM; Neumaier, B; Reske, SN; Schirrmeister, H; Wahl, A1
Barrio, J; Czernin, J; Halpern, BS; Mellinghoff, IK; Phelps, ME; Rozengurt, N; Safaei, A; Satyamurthy, N; Sawyers, CL; Silverman, DH; Stout, D; Tran, C; Waldherr, C; Weber, WA1
Grierson, JR; Krohn, KA; Mankoff, DA; Muzi, M; Peterson, L; Schmidt, RA; Vesselle, H; Wells, JM1
Alauddin, MM; Bornmann, W; Gelovani, JG; Mawlawi, O; Mukhopadhyay, U; Nishii, R; Pal, A; Volgin, AY1

Reviews

1 review(s) available for alovudine and Invasiveness, Neoplasm

ArticleYear
[18F]FLT-PET in oncology: current status and opportunities.
    European journal of nuclear medicine and molecular imaging, 2004, Volume: 31, Issue:12

    Topics: Animals; Dideoxynucleosides; Humans; Neoplasm Invasiveness; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index

2004

Trials

2 trial(s) available for alovudine and Invasiveness, Neoplasm

ArticleYear
Clinical relevance of imaging proliferative activity in lung nodules.
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Solitary Pulmonary Nodule

2005
Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:2

    Topics: Algorithms; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Dideoxynucleosides; Humans; Image Interpretation, Computer-Assisted; Kinetics; Lung Neoplasms; Metabolic Clearance Rate; Models, Biological; Neoplasm Invasiveness; Neoplasm Staging; Organ Specificity; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution

2005

Other Studies

5 other study(ies) available for alovudine and Invasiveness, Neoplasm

ArticleYear
Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:9

    Topics: Aged; Algorithms; Carcinoma, Hepatocellular; Dideoxynucleosides; Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2009
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:7

    Topics: Animals; Beta Particles; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Female; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Receptors, Urokinase Plasminogen Activator; Substrate Specificity

2012
High 18F-fluorothymidine uptake for invasive thymoma.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:10

    Topics: Biological Transport; Dideoxynucleosides; Female; Humans; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Thymoma; Thymus Neoplasms

2012
Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005, Volume: 46, Issue:1

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Mice; Mice, SCID; Neoplasm Invasiveness; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Radiopharmaceuticals; Treatment Outcome

2005
Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.
    European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:5

    Topics: Animals; Arabinofuranosyluracil; Cell Proliferation; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2008